Boxer Capital, LLC - Dec 17, 2021 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
10%+ Owner
Signature
Boxer Capital, LLC, By: /s/ Aaron Davis, Aaron Davis, Chief Executive Officer
Stock symbol
TYRA
Transactions as of
Dec 17, 2021
Transactions value $
$1,640,313
Form type
4
Date filed
12/21/2021, 04:00 PM
Previous filing
Nov 24, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Purchase $1.64M +125K +1.98% $13.12 6.45M Dec 17, 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) MVA Investors, LLC, (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the "Boxer Group"). Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
F2 These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital.
F3 Reflects the weighted average purchase price. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. The range of prices for such transaction is $12.6212 to $13.5758.